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Aurora B answers an XIST-ential question
E
arly in development, mammalian 
female cells counteract their dou-
ble dose of X chromosomes by 
coating one of them with a large RNA 
named XIST. The RNA binds to the same 
X chromosome from which it is tran-
scribed and initiates a series of events 
leading to the chromosome’s permanent 
silencing (1). Hall et al. exploit the fact 
that XIST temporarily dissociates from 
the X chromosome during mitosis and 
fi  nd that Aurora B kinase helps regulate 
the RNA’s chromatin binding (2).
Although more than 10 years have 
passed since XIST was shown to paint 
the inactivated X (Xi) chromosome (3), 
little is known of how the 14-kb, non-
coding transcript binds its target. “We 
know it doesn’t just bind the DNA, but 
no specific binding proteins have been 
identified,” says lead author Lisa Hall. 
Biochemical approaches to finding pro-
tein partners may have been hampered 
by XIST’s large size and tight associa-
tion with the X chromosome, making it 
hard to extract the RNA complex and 
study it in vitro. So Hall, together with 
colleagues in Jeanne Lawrence’s labo-
ratory at the University of Massachu-
setts Medical School, Worcester, took 
an in vivo approach—
mimicking the events that 
cause XIST to drop off 
the Xi in early prophase.
Hall and colleagues 
found that treating cells 
with an inhibitor of pro-
tein phosphatase 1 (PP1) 
caused XIST to be released 
from the Xi in interphase 
cells. PP1 usually keeps the 
kinase Aurora B in check until the start of 
mitosis, so the team wondered whether 
XIST’s premature release was driven by 
increased Aurora B activity. XIST was 
no longer released in interphase cells if 
PP1 and Aurora B were both inhibited. 
Moreover, inhibiting Aurora B with either 
drugs or a specifi  c siRNA caused XIST to 
be retained on the Xi even in mitotic cells.
Lawrence says that the team was 
excited to identify Aurora B as a regula-
tor of XIST. Their previous studies had 
suggested that a broader chromatin orga-
nizer might control XIST binding, partic-
ularly during cancer when the regulation 
of XIST and the Xi often goes awry (4). 
Aurora B fi  ts the bill perfectly as it lo-
calizes to the chromosome arms at pro-
phase, phosphorylates several chromatin 
proteins including histone H3, and is 
frequently activated in cancer cells.
It remains unclear exactly how Au-
rora B promotes XIST’s loss from the Xi. 
The researchers initially 
suspected that histone H3 
phosphorylation might be 
involved but found that 
this wasn’t enough to cause 
XIST’s mitotic release. 
“There are probably multiple 
places that XIST anchors to 
chromatin,” says Lawrence. 
“In order to release it, you 
have to modify multiple 
points. So we can’t say H3 phosphory-
lation isn’t involved at all, but we can 
conclude that it’s not suffi  cient to knock 
XIST off the chromosome.”
Further studies on the mitotic loss 
of XIST should help identify these dif-
ferent anchor points and determine how 
they are modifi  ed to promote or block 
RNA binding. The approach can also 
discover chromatin changes downstream 
of XIST. The Xi is usually ubiquitinated 
on histone H2A, and this mark is also 
lost during mitosis (5). Hall et al. found 
that deubiquitination closely follows 
XIST uncoating, and if XIST release was 
blocked by inhibiting Aurora B, H2A 
remained ubiquitinated.
XIST may, in fact, represent a 
broader class of noncoding RNAs that 
associate with and regulate heterochro-
matin (6). “We hope that manipulating 
binding in vivo provides a new way to 
study RNA–chromatin interactions that 
other labs will build on,” says Law-
rence. “It will be interesting to deter-
mine if these other RNAs mirror the 
behavior of XIST and are controlled by 
the same mechanism.”
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(L-R) Meg Byron, Lisa Hall, and 
Jeanne Lawrence, together with 
Gayle Pageau, take a new approach 
to studying the interaction of XIST 
RNA with the inactive X chromosome. 
Although XIST initiates the silencing 
of the chromosome, the RNA (green) 
is temporarily released during mitosis 
(left). By manipulating XIST binding 
in vivo, Hall et al. discover that 
Aurora B kinase regulates the RNA’s 
association with chromatin: XIST is 
retained on the X chromosome in 
mitotic cells lacking Aurora B (right).
“Manipulating 
binding in vivo 
provides a new 
way to study 
RNA–chromatin 
interactions.”
Mitotic release of chromatin-binding RNA gives insight into X chromosome silencing.
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